MAP
Moody Aldrich Partners Portfolio holdings
AUM
$517M
This Quarter Return
+7.18%
1 Year Return
+38.15%
3 Year Return
+181.18%
5 Year Return
+335.56%
10 Year Return
–
AUM
$540M
AUM Growth
+$540M
(-1.8%)
Cap. Flow
-$25.1M
Cap. Flow
% of AUM
-4.64%
Top 10 Holdings %
Top 10 Hldgs %
18.67%
Holding
222
New
30
Increased
26
Reduced
119
Closed
26
Top Buys
| 1 |
Core Scientific
CORZ
|
$4.85M |
| 2 |
Limbach Holdings
LMB
|
$4.43M |
| 3 |
ECG
Everus Construction Group, Inc.
ECG
|
$4.36M |
| 4 |
Boot Barn
BOOT
|
$4.23M |
| 5 |
Archrock
AROC
|
$3.97M |
Top Sells
| 1 |
Credo Technology Group
CRDO
|
$9.59M |
| 2 |
ICF International
ICFI
|
$7.55M |
| 3 |
VRNA
Verona Pharma
VRNA
|
$7.33M |
| 4 |
ALTR
Altair Engineering Inc. Class A Common Stock
ALTR
|
$7.19M |
| 5 |
Amphastar Pharmaceuticals
AMPH
|
$4.87M |
Sector Composition
| 1 | Financials | 23.65% |
| 2 | Healthcare | 14.74% |
| 3 | Industrials | 14.59% |
| 4 | Technology | 12.45% |
| 5 | Consumer Discretionary | 11.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Fabrinet
FN
$12.1B
| $2.97M | 0.55% |
13,524
-428
| -3% | -$94.1K |
|
77
Napco Security Technologies
NSSC
$1.42B
| $2.82M | 0.52% |
79,382
+6,954
| +10% | +$247K |
|
78
BridgeBio Pharma
BBIO
$9.91B
| $2.74M | 0.51% |
99,684
-23,825
| -19% | -$654K |
|
79
Franklin Electric
FELE
$4.29B
| $2.73M | 0.51% |
28,048
-895
| -3% | -$87.2K |
|
80
American Woodmark
AMWD
$922M
| $2.64M | 0.49% |
33,239
-1,954
| -6% | -$155K |
|
81
Protagonist Therapeutics
PTGX
$3.62B
| $2.6M | 0.48% |
67,415
-51,872
| -43% | -$2M |
|
82
Hilton Grand Vacations
HGV
$4.2B
| $2.58M | 0.48% |
66,249
-1,887
| -3% | -$73.5K |
|
83
Asbury Automotive
ABG
$4.99B
| $2.56M | 0.47% |
10,545
-285
| -3% | -$69.3K |
|
84
Janus Henderson
JHG
$6.86B
| $2.5M | 0.46% |
58,828
| – | – |
|
85
Sportradar
SRAD
$9.03B
| $2.48M | 0.46% |
+143,064
| New | +$2.48M |
|
86
Insmed
INSM
$30.3B
| $2.45M | 0.45% |
+35,478
| New | +$2.45M |
|
87
Rambus
RMBS
$7.93B
| $2.42M | 0.45% |
45,712
-1,347
| -3% | -$71.2K |
|
88
Alkermes
ALKS
$4.95B
| $2.37M | 0.44% |
82,473
-2,434
| -3% | -$70K |
|
89
Genworth Financial
GNW
$3.51B
| $2.37M | 0.44% |
339,172
| – | – |
|
90
Praxis Precision Medicines
PRAX
$980M
| $2.36M | 0.44% |
30,677
-928
| -3% | -$71.4K |
|
91
AllianceBernstein
AB
$4.37B
| $2.2M | 0.41% |
59,294
| – | – |
|
92
Werner Enterprises
WERN
$1.7B
| $2.1M | 0.39% |
58,353
-1,666
| -3% | -$59.8K |
|
93
NewAmsterdam Pharma
NAMS
$2.8B
| $2.03M | 0.38% |
79,145
-137,348
| -63% | -$3.53M |
|
94
Affiliated Managers Group
AMG
$6.55B
| $2.02M | 0.38% |
+10,948
| New | +$2.02M |
|
95
Hartford Financial Services
HIG
$37.4B
| $2.02M | 0.37% |
18,494
| – | – |
|
96
Enact Holdings
ACT
$5.57B
| $1.97M | 0.37% |
60,904
| – | – |
|
97
Viatris
VTRS
$12.3B
| $1.96M | 0.36% |
157,316
| – | – |
|
98
Plains All American Pipeline
PAA
$12.3B
| $1.83M | 0.34% |
107,166
| – | – |
|
99
SLM Corp
SLM
$6.44B
| $1.78M | 0.33% |
+64,408
| New | +$1.78M |
|
100
Toll Brothers
TOL
$13.6B
| $1.77M | 0.33% |
14,059
| – | – |
|